Viridian Therapeutics Correlations

VRDN Stock

USD 11.79 0.01 0.08%

The current 90-days correlation between Viridian Therapeutics and Amphastar P is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viridian Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viridian Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Viridian Therapeutics Correlation With Market

Good diversification

The correlation between Viridian Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.

Moving together with Viridian Stock

0.86	A	Agilent Technologies	Pair Corr
0.84	ME	23Andme Holding	Pair Corr
0.84	VANI	Vivani Medical	Pair Corr
0.85	DNLI	Denali Therapeutics	Pair Corr
0.73	DNTH	Dianthus Therapeutics	Pair Corr
0.89	VCEL	Vericel Corp Ord	Pair Corr
0.89	VCYT	Veracyte	Pair Corr
0.65	VERV	Verve Therapeutics	Pair Corr
0.95	VERA	Vera Therapeutics	Pair Corr
0.73	DRTS	Alpha Tau Medical	Pair Corr
0.8	CDIOW	Cardio Diagnostics	Pair Corr
0.74	SABSW	SAB Biotherapeutics	Pair Corr
0.7	VINC	Vincerx Pharma	Pair Corr
0.86	VKTX	Viking Therapeutics	Pair Corr
0.76	DYAI	Dyadic International	Pair Corr
0.81	VRAX	Virax Biolabs Group	Pair Corr
0.66	VRCA	Verrica Pharmaceuticals	Pair Corr
0.88	VRPX	Virpax Pharmaceuticals	Pair Corr
0.86	VTGN	VistaGen Therapeutics	Pair Corr
0.87	VTRS	Viatris Sell-off Trend	Pair Corr
0.91	VTYX	Ventyx Biosciences	Pair Corr

Moving against Viridian Stock

0.53	VALN	Valneva SE ADR	Pair Corr
0.63	VRTX	Vertex Pharmaceuticals Sell-off Trend	Pair Corr
0.58	EDSA	Edesa Biotech	Pair Corr
0.5	VRNA	Verona Pharma PLC	Pair Corr
0.33	VTVT	vTv Therapeutics	Pair Corr

Related Correlations Analysis

	ITCI	AMPH	ASRT	ANIP	ALKS	RDY	COLL	PCRX	CYTH	LFCR
ITCI		-0.65	-0.46	0.61	0.69	-0.86	-0.4	0.74	0.49	-0.25	ITCI
AMPH	-0.65		0.74	-0.72	-0.56	0.82	0.76	-0.24	-0.38	0.05	AMPH
ASRT	-0.46	0.74		-0.75	-0.09	0.61	0.52	-0.15	0.02	-0.07	ASRT
ANIP	0.61	-0.72	-0.75		0.29	-0.58	-0.32	0.31	-0.09	0.3	ANIP
ALKS	0.69	-0.56	-0.09	0.29		-0.67	-0.39	0.51	0.62	-0.22	ALKS
RDY	-0.86	0.82	0.61	-0.58	-0.67		0.6	-0.56	-0.56	0.3	RDY
COLL	-0.4	0.76	0.52	-0.32	-0.39	0.6		-0.06	-0.49	0.06	COLL
PCRX	0.74	-0.24	-0.15	0.31	0.51	-0.56	-0.06		0.4	-0.47	PCRX
CYTH	0.49	-0.38	0.02	-0.09	0.62	-0.56	-0.49	0.4		-0.52	CYTH
LFCR	-0.25	0.05	-0.07	0.3	-0.22	0.3	0.06	-0.47	-0.52		LFCR
	ITCI	AMPH	ASRT	ANIP	ALKS	RDY	COLL	PCRX	CYTH	LFCR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RDY	+ 0.82	AMPH
COLL	+ 0.76	AMPH
PCRX	+ 0.74	ITCI
ASRT	+ 0.74	AMPH
ALKS	+ 0.69	ITCI
CYTH	+ 0.62	ALKS

High negative correlations

RDY	- 0.86	ITCI
ANIP	- 0.75	ASRT
ANIP	- 0.72	AMPH
RDY	- 0.67	ALKS
AMPH	- 0.65	ITCI
RDY	- 0.58	ANIP

Risk-Adjusted Indicators

There is a big difference between Viridian Stock performing well and Viridian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viridian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ITCI	1.53	0.85	1.43	1.19	0.00	(1.67)	1.77	(0.80)	34.42
AMPH	1.75	(0.54)	0.00	(1.38)	0.00	0.00	3.23	(5.00)	14.01
ASRT	2.39	(0.51)	0.00	(0.77)	0.00	0.00	3.75	(6.35)	14.19
ANIP	1.70	0.36	0.19	0.28	1.96	(1.98)	3.04	(2.99)	18.94
ALKS	1.49	0.11	0.00	(0.03)	0.00	0.00	3.78	(2.78)	12.52
RDY	1.15	(0.27)	0.00	(0.85)	0.00	0.00	1.78	(2.82)	10.91
COLL	1.87	(0.04)	0.00	(0.24)	0.00	0.00	3.47	(3.32)	18.67
PCRX	2.37	0.68	0.30	1.17	2.11	(2.79)	5.10	(4.53)	16.33
CYTH	4.64	0.47	0.10	2.39	5.50	(6.12)	10.00	(10.14)	76.39
LFCR	3.02	(0.39)	0.00	(1.24)	0.00	0.00	3.85	(9.84)	36.73

Viridian Therapeutics Corporate Management

Seth Harmon	Principal Accounting	Profile
Anthony Casicano	Chief Officer	Profile
Kristian MBA	Chief CFO	Profile
Melissa Manno	Chief Officer	Profile
Anthony Casciano	Chief Officer	Profile
Jennifer JD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC